We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $42.5B
1-Year Est. Return 18.19%
This Fund
S&P 500
This Quarter Est. Return
+5.94%
1 Year Est. Return
+18.19%
3 Year Est. Return
+63.85%
5 Year Est. Return
+89.78%
10 Year Est. Return
+309.54%
AUM
$27.2B
AUM Growth
+$1.16B
Cap. Flow
-$132M
Cap. Flow %
-0.48%
Top 10 Hldgs %
42.7%
Holding
298
New
27
Increased
73
Reduced
117
Closed
9

Top Buys

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$261M
2
MAR icon
Marriott International
MAR
+$99.1M
3
ZTS icon
Zoetis
ZTS
+$41.2M
4
PG icon
Procter & Gamble
PG
+$27M
5
ADBE icon
Adobe
ADBE
+$19.3M

Top Sells

Rank Stock Value
1
EV
Eaton Vance Corp.
EV
+$351M
2
CB icon
Chubb
CB
+$59.3M
3
AAPL icon
Apple
AAPL
+$49.6M
4
ASML icon
ASML
ASML
+$16.9M
5
JPM icon
JPMorgan Chase
JPM
+$14.9M

Sector Composition

Rank Sector Weight
1 Technology 21.13%
2 Financials 20.71%
3 Consumer Staples 19.03%
4 Communication Services 10.95%
5 Healthcare 9.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WMT icon
51
Walmart Inc
WMT
$865B
$110M 0.4%
2,424,735
-174,801
-7% -$8.1M
LIN icon
52
Linde
LIN
$214B
$110M 0.4%
391,149
-9,118
-2% -$2.37M
VRSK icon
53
Verisk Analytics
VRSK
$24.3B
$109M 0.4%
618,142
+1,059
+0.2% +$194K
MAR icon
54
Marriott International
MAR
$88.8B
$107M 0.4%
+725,587
New +$99.1M
Z icon
55
Zillow
Z
$7.46B
$102M 0.37%
786,240
STT icon
56
State Street
STT
$51.7B
$98.6M 0.36%
1,174,093
-4,360
-0.4% -$338K
DEO icon
57
Diageo
DEO
$49.1B
$91.8M 0.34%
558,958
-11,908
-2% -$1.95M
INFO
58
DELISTED
IHS Markit Ltd. Common Shares
INFO
$87.3M 0.32%
901,631
+1,996
+0.2% +$182K
INTC icon
59
Intel
INTC
$514B
$87.1M 0.32%
1,360,888
-33,635
-2% -$2M
BRK.B icon
60
Berkshire Hathaway Class B
BRK.B
$1.1T
$86.2M 0.32%
337,551
+4,223
+1% +$1.03M
AXP icon
61
American Express
AXP
$221B
$85.1M 0.31%
601,860
-9,170
-2% -$1.21M
KMPR icon
62
Kemper
KMPR
$1.64B
$78.7M 0.29%
987,562
-3,400
-0.3% -$262K
ZTS icon
63
Zoetis
ZTS
$30.4B
$74.5M 0.27%
473,253
+259,974
+122% +$41.2M
COP icon
64
ConocoPhillips
COP
$164B
$65.5M 0.24%
1,237,502
-28,912
-2% -$1.42M
MASI
65
DELISTED
Masimo
MASI
$64.9M 0.24%
282,724
+13,577
+5% +$3.41M
OTIS icon
66
Otis Worldwide
OTIS
$26.7B
$55.8M 0.21%
815,249
-10,501
-1% -$686K
ZG icon
67
Zillow
ZG
$7.61B
$51.6M 0.19%
393,120
TGT icon
68
Target
TGT
$72.1B
$49.6M 0.18%
250,647
-1,270
-0.5% -$238K
PSX icon
69
Phillips 66
PSX
$103B
$46.2M 0.17%
566,163
-20,017
-3% -$1.57M
BX icon
70
Blackstone
BX
$96.3B
$44.5M 0.16%
596,934
+100,475
+20% +$6.94M
K
71
DELISTED
Kellanova
K
$42.2M 0.16%
709,307
-13,140
-2% -$735K
TDY icon
72
Teledyne Technologies
TDY
$27.7B
$41.3M 0.15%
99,903
HD icon
73
Home Depot
HD
$310B
$41.3M 0.15%
135,337
-6,633
-5% -$1.83M
NVS icon
74
Novartis
NVS
$264B
$36.5M 0.13%
427,225
+3,370
+0.8% +$302K
WBA
75
DELISTED
Walgreens Boots Alliance
WBA
$31.3M 0.12%
570,125
-20,463
-3% -$1.01M

Similar funds

Fayez Sarofim & Co's Q1 2021 Portfolio in Review

As of Q1 2021, Fayez Sarofim & Co held 298 positions worth $27.2B, up 4.5% from $26B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Fayez Sarofim & Co's Q1 2021 filing shows 27 new, 73 increased, 117 reduced and 9 closed positions. Its largest new stake was Morgan Stanley: 3,402,625 shares worth $264M. The largest sale was Eaton Vance Corp., an estimated $351M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Staples.

  • Fayez Sarofim & Co's largest Q1 2021 buy was Morgan Stanley: 3,402,625 shares worth $264M.
  • Fayez Sarofim & Co added most to Zoetis in Q1 2021, an estimated $41.2M increase.
  • Fayez Sarofim & Co's biggest Q1 2021 reduction was Chubb, cutting an estimated $59.3M.
  • Fayez Sarofim & Co fully exited Eaton Vance Corp. in Q1 2021, selling an estimated $351M.
  • Fayez Sarofim & Co's ten largest holdings make up 43% of its $27.2B portfolio in Q1 2021.
  • Fayez Sarofim & Co opened 27 new positions and closed 9 in Q1 2021.
  • Fayez Sarofim & Co's portfolio value rose 4.5% quarter-over-quarter to $27.2B.

Based on Fayez Sarofim & Co's 13F filing for Q1 2021, filed 13 May 2021.